{"doi":"10.3949/ccjm.62.4.212","title":"Dopamine agonists in the treatment of Parkinson's disease","abstract":null,"journal":"Cleveland Clinic Journal of Medicine","year":1995,"id":42675,"datarank":0.6590176566813236,"base_score":2.3978952727983707,"endowment":2.3978952727983707,"self_citation_contribution":0.3596842909197557,"citation_network_contribution":0.29933336576156794,"self_endowment_contribution":0.3596842909197557,"citer_contribution":0.29933336576156794,"corpus_percentile":null,"corpus_rank":null,"citation_count":10,"citer_count":8,"citers_with_citation_signal":5,"citers_with_endowment":5,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":null,"is_data_producer":false,"deposit_databanks":null,"is_oa":false,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":null,"fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":203946,"name":"W. C. Koller","orcid":null,"position":1,"is_corresponding":false},{"id":203945,"name":"R. Pahwa","orcid":null,"position":0,"is_corresponding":false}],"reference_count":0,"raw_metadata":{"has_enrichment":true,"base_score":2.3978952727983707,"endowment":2.3978952727983707,"datacite_reuse_total":0,"file_count":0,"downloads":0,"views":0,"has_version_chain":false,"is_dataset":false,"is_oa":false,"pmid":"7641388","pmcid":null,"openalex_id":"https://openalex.org/W2324118772","authors":[],"funders":[],"total_grants":0,"fwci":0.3204,"citation_percentile":0.63465993,"influential_citations":1,"citation_trend":[{"year":2022,"count":1},{"year":2025,"count":1}],"oa_status":"closed","license":null,"oa_locations":[{"url":"https://doi.org/10.3949/ccjm.62.4.212","host_type":"journal"},{"url":"https://pubmed.ncbi.nlm.nih.gov/7641388","host_type":"repository"}],"fields_of_study":["Parkinson's Disease and Spinal Disorders","Glycogen Storage Diseases and Myoclonus","Parkinson's Disease Mechanisms and Treatments","Medicine","Bromocriptine","Humans","Parkinson Disease","Pergolide"],"mesh_terms":["Bromocriptine","Humans","Parkinson Disease","Pergolide"],"keywords":["Pergolide","Bromocriptine","Medicine","Levodopa","Dopamine agonist","Dose","Dopamine","Agonist","Parkinson's disease","Prolactin","Pharmacology","Internal medicine","Anesthesia","Disease","Dopaminergic"],"sdg_mappings":[{"sdg_number":0,"sdg_label":"Good health and well-being"}],"linked_datasets":[],"clinical_trials":[],"software_tools":[],"database_accessions":[],"source":"live","citation_network_status":"fetched"},"created_at":"2026-06-14T04:42:24.209722Z","pmid":null,"pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}